Beijing Friendship Hospital, Capital medical University
Beijing, Beijing Municipality, China
Location status: Recruiting
NCT Number: NCT05833659
There are controversies about breast implant-based reconstruction techniques. Our center pioneered single-port insufflation endoscopic nipple-sparing mastectomy (SIE-NSM) combined with stage I prosthesis reconstruction. The study's primary objective is to compare single-port endoscopic NSM combined with pre-pectoral breast reconstruction to the subpectoral breast reconstruction group regarding breast satisfaction.
This study is an ambispective cohort study. The study will be conducted at Beijing Friendship Hospital, affiliated with Capital Medical University. Patients will be enrolled retrospectively from January 2014 to March 2022 by reviewing the medical records and recruited prospectively from March 2022 to March 2025. The two cohorts are the pre-pectoral breast reconstruction cohort and the subpectoral breast reconstruction cohort, both following single-port insufflation endoscopic nipple-sparing mastectomy. The primary outcome of this study is postoperative breast satisfaction, which the BREAST-Q score will measure. The different variables will be compared using the Χ2 test for categorical variables and the Mann-Whitney test for continuous variables.
Interested in participating?
Request Info18 year–70 year
Female
Observational
Beijing, Beijing Municipality, China
Location status: Recruiting
Sample size and statistical analysis This study is an ambispective cohort study. According to the previous retrospective research data of the center, the breast satisfaction score is the main research object. The standard deviation was 2.6, the non-inferiority margin was 0.15, the test level was α=0.05, β=0.2, and a one-sided test was performed. Eighty patients will be needed for two cohorts in a 1:1 ratio. Considering the 10% loss to follow-up rate, 44 patients will be required to be enrolled in each group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group A:The prepectoral breast reconstruction. Group B:The subpectoral breast reconstruction
Time frame: 12 months after operation
measured by BREAST-Q score
Time frame: 12 months after operation
measured by BREAST-Q score
Time frame: 12 months after operation
confirmed by the doctor's physical examination
Time frame: within 30 days after surgery
according to Clavien-Dindo system
Time frame: 12 months after operation
physical examination or imaging examination with histologically confirmed
Contact information is provided by the study sponsor or research team.
Beijing Friendship Hospital
Other
The Comparison Between Prepectoral Breast Reconstruction and Subpectoral Breast Reconstruction Following Single-port Insufflation Endoscopic Nipple-sparing Mastectomy
Acronym: RESPECT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05535192
Breast Cancer, Breast Cancer Female
Boston, Massachusetts, United States
View Trial DetailsNCT05595577
Breast Diseases, Breast Neoplasms
Winston-Salem, North Carolina, United States
View Trial DetailsNCT07042581
Breast Cancer, Breast Carcinoma In Situ
Basking Ridge, New Jersey, United States
View Trial DetailsNCT07095114
Adenocarcinoma, Breast Carcinoma In Situ
Detroit, Michigan, United States
View Trial Details